cysteamine has been researched along with Acquired Immunodeficiency Syndrome in 1 studies
*Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Guzman, RN; McDonnell, NB; Rice, WG; Summers, MF; Turpin, JA | 1 |
1 other study(ies) available for cysteamine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Anti-HIV Agents; Capsid; Capsid Proteins; Cells, Cultured; Cystamine; Disulfiram; Ditiocarb; gag Gene Products, Human Immunodeficiency Virus; Gene Products, gag; Humans; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Thiamine; Viral Proteins; Zinc Fingers | 1997 |